Gara Jalqabaatti › Dhibee Harkaa (Hepatocellular Carcinoma) › Ohio › Cleveland
Qorannoo klinikaalii Dhibee Harkaa (Hepatocellular Carcinoma) Cleveland, OH keessatti
Qorannoo 18 Dhibee Harkaa (Hepatocellular Carcinoma) f Cleveland fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
The Vanguard Study: Testing a New Way to Screen for Cancer
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Louis Stokes Cleveland VA Medical Center, Cleveland
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Exelixis Clinical Site #10, Cleveland
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Namoota walitti qabaa jiraSadarkaa 1/2
- University Hospitals Cleveland Medical Center, Cleveland
National Liver Cancer Screening Trial
Namoota walitti qabaa jiraSadarkaa 4
- The Cleveland Clinic, Cleveland
A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Namoota walitti qabaa jira
- University Hospital Cleveland Medical Center, Cleveland
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Cleveland Clinic Foundation, Cleveland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Namoota walitti qabaa jiraSadarkaa 3
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · Miili 10 fagaatti
- UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · Miili 22 fagaatti
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University Hospitals Cleveland Medical Center, Cleveland
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
Namoota walitti qabaa jiraQorannoo ilaalaa
- Cleveland Clinic, Cleveland
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Namoota walitti qabaa jiraSadarkaa 1
- Clinical Trial Site, Cleveland
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Namoota walitti qabaa jira
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
Namoota walitti qabaa jiraSadarkaa 2
- Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Namoota walitti qabaa jiraSadarkaa 1/2
- Cleveland Clinic Lerner College of Medicine, Cleveland
HOPE Against Cancer Recurrence in HCC
Namoota walitti qabaa jiraSadarkaa 4
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Mayfield Heights · Miili 12 fagaatti
The Dragon PLC Trial (DRAGON-PLC)
Namoota walitti qabaa jira
- Cleveland Clinic, Cleveland
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Namoota walitti qabaa jiraSadarkaa 1/2
- Cleveland Clinic, Cleveland
Qorannoo Dhibee Harkaa (Hepatocellular Carcinoma) magaalota biroo keessatti
- Houston, TXQorannoo 31
- New York City, NYQorannoo 24
- Dallas, TXQorannoo 19
- Los Angeles, CAQorannoo 19
- Boston, MAQorannoo 18
- Chicago, ILQorannoo 16
- Philadelphia, PAQorannoo 16
- Pittsburgh, PAQorannoo 15
- San Francisco, CAQorannoo 14
- Orange, CAQorannoo 14
- Jacksonville, FLQorannoo 14
- San Antonio, TXQorannoo 13
Qorannoo biroo Cleveland keessatti
- Kansara Qara'a Non-Small CellQorannoo 43
- Saree (Gosoota Hunda)Qorannoo 36
- Saree OljooQorannoo 35
- Kansarii ProstateQorannoo 34
- Cufama OnneeQorannoo 33
- Kansarii OvariiQorannoo 30
- Kansara MetastatikiiQorannoo 30
- Dhibee QaraQorannoo 26
- Kansarii ColorectalQorannoo 24
- Dhibee Onneessaa fi DhiigaQorannoo 22
- Kansa EndometiriyaaliiQorannoo 20
- Leukemia Myeloidii HamaaQorannoo 20
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.